Showing 504 results

Filters Content type: News, Editors' picks, About HIV Topic: Resistance

Poor adherence and the subsequent development of drug resistance is one reason why HIV treatment can fail. A drug-resistant HIV strain is one which is less susceptible to the effects of one or more anti-HIV drugs.

Resistance

Darunavir Resistance Development Is Rare in HIV Treatment

Editor's pick
Infectious Disease Advisor
1 September 2020
Resistance

“Unprecedented” case of transmission of four-class resistant HIV virus reported in France

News
11 August 2020
Resistance

Doravirine Benefits HIV-1 Patients with Common Resistance Associated Mutations

Editor's pick
Contagion Live
8 July 2020
HIV treatment for children & young people

Combatting Virologic Failure in Children with HIV using Targeted Drug Resistance Testing

Editor's pick
Contagion Live
8 July 2020
Resistance

Recycling tenofovir better than switch to second-line zidovudine

News
6 July 2020
Resistance

HIV drugs have transformed the lives of people in rich nations. In Papua New Guinea, the virus is mutating

Editor's pick
ABC
22 June 2020
HIV treatment for children & young people

High levels of drug resistance among infants newly diagnosed with HIV in sub-Saharan Africa

News
17 June 2020
Adherence

US: Factors Contributing to Poor ART Adherence, HIV-1 Drug Resistance Explored

Editor's pick
Monthly Prescribing Reference
16 June 2020
PrEP science

PrEP and drug resistance A research briefing

About HIV
June 2020
Changing treatment

Delaying treatment changes when first-line ART fails costs lives, says South African study

News
28 April 2020
PrEP science

Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds

News
13 March 2020
PrEP science

Does PrEP cause more HIV drug resistance? Yes, some

News
12 February 2020
Resistance

How HIV develops resistance to key drugs discovered

Editor's pick
EurekAlert
31 January 2020
Resistance

Proviral DNA resistance testing allows treatment switches without viral rebound

News
22 January 2020
Resistance

Drug-resistance or viral-load testing required before switch to dolutegravir in Togo

News
16 December 2019
Resistance

WHO unveils plan to tackle rising HIV drug resistance in Africa

Editor's pick
World Health Organization
9 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
Resistance

FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations

Editor's pick
Food & Drug Administration
6 November 2019
New & experimental HIV treatments

Ibalizumab monoclonal antibody is effective in real-world use

News
7 October 2019
Changing treatment

‘Alarming’ rates of second-line HIV treatment failure in sub-Saharan Africa

Editor's pick
Avert
22 August 2019
People with limited treatment options

Dramatic decline in proportion of people with extensive resistance to anti-HIV medications

News
6 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019